AiDAPT: automated insulin delivery amongst pregnant women with type 1 diabetes: a multicentre randomized controlled trial – study protocol

BACKGROUND: Pregnant women with type 1 diabetes strive for tight glucose targets (3.5-7.8 mmol/L) to minimise the risks of obstetric and neonatal complications. Despite using diabetes technologies including continuous glucose monitoring (CGM), insulin pumps and contemporary insulin analogues, most w...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Tara T. M., Collett, Corinne, Man, Mei-See, Hammond, Matt, Shepstone, Lee, Hartnell, Sara, Gurnell, Eleanor, Byrne, Caroline, Scott, Eleanor M., Lindsay, Robert S., Morris, Damian, Brackenridge, Anna, Dover, Anna R., Reynolds, Rebecca M., Hunt, Katharine F., McCance, David R., Barnard-Kelly, Katharine, Rankin, David, Lawton, Julia, Bocchino, Laura E., Sibayan, Judy, Kollman, Craig, Wilinska, Malgorzata E., Hovorka, Roman, Murphy, Helen R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982306/
https://www.ncbi.nlm.nih.gov/pubmed/35382796
http://dx.doi.org/10.1186/s12884-022-04543-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982306/
https://www.ncbi.nlm.nih.gov/pubmed/35382796
http://dx.doi.org/10.1186/s12884-022-04543-z

Ejemplares similares